Before subscribing to a U.S. IPO, read the latest prospectus and check how the company makes money, what could threaten its business, where the offering proceeds will go, how the share count and ownership will change, and how the price and underwriting terms compare with the company’s disclosed financial position. Read related sections together: the summary alone cannot answer those questions.
This checklist follows the U.S. framework described by the SEC and Investor.gov. Prospectus rules and filing sources differ by country, so investors elsewhere should also consult their local regulator.
Start with the latest filing, not an older summary
A U.S. IPO registration statement is typically filed on Form S-1, with the prospectus in Part I. Look up the issuer on SEC EDGAR and check the most recent registration statement and any amendments: disclosures and offering terms can change while the registration is under review.
After the registration statement becomes effective, the issuer typically files a final prospectus, often identified as a 424B3 or 424B4. That filing generally includes the final offering price. A preliminary price range is not the final price, so do not base a subscription decision on it as if the terms were settled.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →#1 Best Overall
The SEC’s October 14, 2022 Investor.gov bulletin makes an important distinction: effectiveness is not SEC approval of an IPO’s merits, a recommendation, or a guarantee that the disclosed information is complete or accurate. SEC staff review focuses on disclosure compliance; it does not decide whether the investment is suitable for you.
Check what the company does and how it plans to grow
Use the prospectus summary to get oriented, then verify its claims in the Business section and management’s discussion and analysis (MD&A). Look for the products or services, markets, strategy, competitors, and important suppliers and customers. Ask whether the company’s growth plans depend on assumptions or relationships that the rest of the filing makes look uncertain.
Pay particular attention to customer or supplier concentration. If a small number of relationships account for a significant part of the business, losing or changing one could materially affect results. Consider whether the prospectus explains that exposure and whether the financial statements or MD&A show effects already occurring.
Translate risk factors into specific exposures
Risk factors describe risks management says could significantly affect the business, operations, performance, or securities. Rather than treating the section as a list of boilerplate warnings, sort the risks into the kinds of exposure that matter to this issuer:
Free tools Windows power users keep installed
One-click scans. No signup required.
- Operational: dependence on key suppliers, customers, products, or other business relationships.
- Financial: risks visible in the company’s financial condition or results.
- Competitive: threats connected to competitors, markets, or the company’s stated strategy.
- Legal and regulatory: disclosed litigation or regulatory matters that could affect the business.
- Offering-related: risks tied to the shares, offering terms, or how the IPO is distributed.
Then cross-check those risks against the Business section, MD&A, and financial statements. The prospectus reports issuer disclosure; it does not independently validate every forecast or management’s assessment of risk.
Find out where the offering money will go
In the use-of-proceeds section, identify the stated purposes and how specifically the company allocates the money. Compare those purposes with its financial needs and stated plans. A broad statement that management may use proceeds at its discretion gives management more latitude than a specific allocation.
Also determine whether the IPO consists of new shares issued by the company, shares sold by existing shareholders, or both. Proceeds from shares sold by existing holders go to those sellers, not to the company. The distinction affects how much of the offering funds the issuer’s plans.
Understand dilution and who owns the company
Read the dilution discussion to see how the IPO price compares with pro forma book value and the average price existing shareholders paid for their shares. Review the disclosed share counts and ownership information to understand how the offering changes the capital structure and where new investors stand relative to existing holders.
Compare this information with the offering details: the number of new shares and shares sold by existing holders can help explain who receives the proceeds and how ownership changes. These disclosures describe the structure of the offering; they do not, by themselves, establish that the IPO price is fair.
Read the financial statements with the MD&A
Review the audited financial statements, their notes, and the auditor’s opinion. Use the MD&A alongside them to understand why results and financial condition changed and which factors management says may affect future results. Looking at both helps connect the company’s reported record to the explanations and risks described elsewhere in the filing.
The number of years shown can vary. The SEC’s 2022 Investor.gov bulletin says emerging growth companies and smaller reporting companies may present two years of audited statements, compared with three years for other IPO companies. Do not assume every prospectus has the same reporting period or that this comparison covers every issuer category; check the filing and current requirements that apply.
Assess management, legal matters, and dividend policy
Review the biographies of directors and executives, disclosed significant litigation, and the company’s dividend policy and stated plans. Consider whether the disclosed management and governance experience fit the company’s stage and strategy. The purpose is to understand what the filing says about oversight, leadership, legal exposure, and distributions—not to infer facts the prospectus does not provide.
Examine the price and underwriting terms
The company and underwriters set the offering price through a process that reflects market conditions, analysis, negotiation, and competing interests. Read the Underwriting or Plan of Distribution section for the underwriters’ terms and compensation, and consider those disclosures alongside the issuer’s objectives and financial condition.
Investor.gov cautions that early aftermarket price support may end, after which shares can fall below the offering price. The prospectus and its offering terms do not amount to a prediction of how the shares will trade.
A practical cross-check before subscribing
Before making a decision, make sure you can answer these questions from the current filing:
- Am I reading the latest registration statement or final prospectus, and are the price and terms final?
- What does the company sell, what supports its plans, and are important customers or suppliers concentrated?
- Which disclosed risks connect to evidence in the MD&A or financial statements?
- How much of the offering is new company-issued stock, and how much is sold by existing holders?
- What does the company say it will do with its proceeds, and how much discretion does management retain?
- How do the IPO price, dilution disclosures, share structure, and available financial record fit together?
- What do the underwriting terms and compensation disclose about the distribution?
This is a reading checklist, not a valuation or individualized investment advice. Where a claim or risk is unclear, consider checking it against independent sources and your own financial circumstances.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
